Literature DB >> 21216638

Canine specific ELISA for coagulation factor VII.

Tom Knudsen1, Mads Kjelgaard-Hansen, Mikael Tranholm, Bo Wiinberg, Jes T Clausen, Jens Jacob Hansen, Timothy C Nichols, Marianne Kjalke, Asger L Jensen, Annemarie T Kristensen.   

Abstract

Canine coagulation factor VII (FVII) deficiency can be hereditary or acquired and may cause life threatening bleeding episodes if untreated. FVII procoagulant activity can be measured by FVII activity (FVII:C), but assays for measurement of canine specific FVII antigen (FVII:Ag) have not been available to date. In this study, a canine specific ELISA for measurement of FVII:Ag in plasma was developed and validated. The FVII:Ag ELISA correctly diagnosed homozygous and heterozygous hereditary FVII deficiency. Together with activity based assays, such as FVII:C, the FVII:Ag ELISA should be valuable in the diagnosis of hereditary canine FVII deficiency.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21216638      PMCID： PMC3947633          DOI： 10.1016/j.tvjl.2010.11.010

Source DB:  PubMed          Journal:  Vet J        ISSN： 1090-0233            Impact factor:   2.688


  22 in total

1.  Optimization of coagulometric tests that incorporate human plasma for determination of coagulation factor activities in canine plasma.

Authors:  R Mischke
Journal:  Am J Vet Res       Date:  2001-04       Impact factor: 1.156

2.  Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.

Authors:  T Nakagaki; D C Foster; K L Berkner; W Kisiel
Journal:  Biochemistry       Date:  1991-11-12       Impact factor: 3.162

3.  Characterization of canine coagulation factor VII and its complex formation with tissue factor: canine-human cross-species compatibility.

Authors:  T Knudsen; A T Kristensen; B B Sørensen; O H Olsen; H R Stennicke; L C Petersen
Journal:  J Thromb Haemost       Date:  2010-05-27       Impact factor: 5.824

4.  The clinical aspects of canine factor-VII deficiency including some case histories.

Authors:  N W Spurling; R Peacock; T Pilling
Journal:  J Small Anim Pract       Date:  1974-04       Impact factor: 1.522

5.  Hereditary factor-VII deficiency in the beagle.

Authors:  N W Spurling; L K Burton; R Peacock; T Pilling
Journal:  Br J Haematol       Date:  1972-07       Impact factor: 6.998

6.  Persistent uterine and vaginal hemorrhage in a beagle with factor VII deficiency.

Authors:  S L Wheeler; K W Weingand; M A Thrall; R J Berg; P D Schwarz; P N Olson
Journal:  J Am Vet Med Assoc       Date:  1984-08-15       Impact factor: 1.936

7.  A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates.

Authors:  Raffaella Toso; Mirko Pinotti; Katherine A High; Eleanor S Pollak; Francesco Bernardi
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

8.  Factor VII deficiency.

Authors:  M V Ragni; J H Lewis; J A Spero; U Hasiba
Journal:  Am J Hematol       Date:  1981       Impact factor: 10.047

9.  Sensitivity of different prothrombin time assays to factor VII deficiency in canine plasma.

Authors:  R Mischke; M Diedrich; I Nolte
Journal:  Vet J       Date:  2003-07       Impact factor: 2.688

10.  Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay.

Authors:  D S Fair
Journal:  Blood       Date:  1983-10       Impact factor: 22.113
View more
  4 in total

1.  Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dog.

Authors:  T Knudsen; A T Kristensen; T C Nichols; H Agersø; A L Jensen; M Kjalke; M Ezban; M Tranholm
Journal:  Haemophilia       Date:  2011-06-06       Impact factor: 4.287

2.  Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVII.

Authors:  Oscar A Marcos-Contreras; Shannon M Smith; Dwight A Bellinger; Robin A Raymer; Elizabeth Merricks; Armida Faella; Giulia Pavani; Shangzhen Zhou; Timothy C Nichols; Katherine A High; Paris Margaritis
Journal:  Blood       Date:  2015-12-23       Impact factor: 22.113

3.  Haemostatic alterations in a group of canine cancer patients are associated with cancer type and disease progression.

Authors:  Eva B Andreasen; Mikael Tranholm; Bo Wiinberg; Bo Markussen; Annemarie T Kristensen
Journal:  Acta Vet Scand       Date:  2012-01-26       Impact factor: 1.695

4.  SvSXP: a Strongylus vulgaris antigen with potential for prepatent diagnosis.

Authors:  Ulla V Andersen; Daniel K Howe; Sriveny Dangoudoubiyam; Nils Toft; Craig R Reinemeyer; Eugene T Lyons; Susanne N Olsen; Jesper Monrad; Peter Nejsum; Martin K Nielsen
Journal:  Parasit Vectors       Date:  2013-04-04       Impact factor: 3.876
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.